29851211000001102: Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)
\UK product\Virtual medicinal product\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Co-proxamol\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing opioid receptor agonist\Product containing methadone analog\Product containing dextropropoxyphene\Product containing dextropropoxyphene and paracetamol\Co-proxamol\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing propionate\Product containing dextropropoxyphene\Product containing dextropropoxyphene and paracetamol\Co-proxamol\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing propionic acid and/or propionic acid derivative (product)\Product containing propionate\Product containing dextropropoxyphene\Product containing dextropropoxyphene and paracetamol\Co-proxamol\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing dextropropoxyphene\Product containing dextropropoxyphene and paracetamol\Co-proxamol\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing paracetamol\Product containing dextropropoxyphene and paracetamol\Co-proxamol\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing methadone analog\Product containing dextropropoxyphene\Product containing dextropropoxyphene and paracetamol\Co-proxamol\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing paracetamol\Product containing dextropropoxyphene and paracetamol\Co-proxamol\Co-proxamol 32.5mg/325mg tablets\Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jul 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

93028201000001116 Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

93028301000001113 Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category Schedule 5 (CD Inv)	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Is a	Co-proxamol 32.5mg/325mg tablets	false	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Is a	Co-proxamol 32.5mg/325mg tablets	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Is a	Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has active ingredient	Paracetamol	false	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has active ingredient	Dextropropoxyphene	false	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has specific active ingredient	Paracetamol	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has specific active ingredient	Dextropropoxyphene hydrochloride	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd) 100 tablet	Has AMP	True	Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
93028201000001116	Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
93028301000001113	Co-proxamol 32.5mg/325mg tablets (Ennogen Healthcare Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module